Blackhawk Growth Corp Advances Human Clinical Trials in Asthmatic AI Technology

Blackhawk Growth Corp. (CSE:BLR)(Frankfurt:0JJ) (the "Corporation" or "Blackhawk"), is pleased to provide an update on Hardenbrook portfolio company - Asthmatic AI

We are pleased to report that Asthmatic AI, a Hardenbrook and Life AI Corp asset (https://www.lifeaicorp.com) has completed 50 participants in human clinical trials and is now working on the next 250 participants as it develops its Asthma attack prediction technology for use in the clinical management of Asthma.

Uniquely, Asthmatic AI uses wearable devices and a mobile application over smartphone to collect data, assess the risk of an asthma attack occurring and then intervene before it occurs. The AI models cross reference an individual's biophysical information such as heart rate, respiratory rate, heart rate variability, blood pressure, cough and wheeze rates with public health data, pollen and location data to interpret an individual's risk of an asthma attack. With over 1000 asthma deaths reported daily according to the World Health Organization and the burden on social, employment, education and family, Asthmatic AI proposes a novel solution for the management of this serious health condition.

Hardenbrook Group works with world class research-intensive organisations to identify valuable intellectual property to invest and commercialize. This provides Blackhawk with the ability to incubate and either M&A or spin out these new innovative companies as a new listing on stock exchanges globally.

Hardenbrook has merged its portfolio of Health tech AI focused companies including Asthmatic AI, Mood AI and Autism AI with a significant pipeline of health-tech AI related projects for launch in the near horizon. Life AI Corp will be the holding company for all health tech AI companies and is also preparing to be spun out and publicly listed.

Blackhawk CEO Justin Hanka (left) and Chairman Anoosh Manzoori (right). The Board's focus is on scalable technology opportunities particularly in AI, health and enviro-tech.

About Blackhawk Growth

Blackhawk is an investment holding company looking to create substantial value for its shareholders through the acquisition and development of high growth companies.

Contact

Justin Hanka. Chief Executive Officer
justin@hardenbrook.group
61433140886

Cautionary Note Regarding Forward-Looking Statement

All statements in this press release, other than statements of historical fact, are "forward-looking information" with respect to the Company within the meaning of applicable securities laws. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company's public filings under the Company's SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

SOURCE: Blackhawk Growth Corp.